102 related articles for article (PubMed ID: 1399941)
1. Post-antibiotic effects of RP 59500 with Staphylococcus aureus.
Nougayrede A; Berthaud N; Bouanchaud DH
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():101-6. PubMed ID: 1399941
[TBL] [Abstract][Full Text] [Related]
2. Post-antibiotic effect of the new streptogramin RP 59500.
Chin NX; Neu HC
Eur J Clin Microbiol Infect Dis; 1992 Jul; 11(7):642-5. PubMed ID: 1396777
[TBL] [Abstract][Full Text] [Related]
3. Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics.
Leclercq R; Nantas L; Soussy CJ; Duval J
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():67-75. PubMed ID: 1399953
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. III. Novel, inducible resistance to macrolide-lincosamide-streptogramin B (MLS) antibiotics.
Inouye Y; Morifuji K; Masumi N; Sugiyama M; Takesue Y; Kodama T; Yokoyama T
Hiroshima J Med Sci; 1993 Sep; 42(3):101-7. PubMed ID: 8253604
[TBL] [Abstract][Full Text] [Related]
5. [Resistance to macrolide antibiotics found in methicillin-resistant Japanese clinical isolates of Staphylococcus aureus in 1996].
Nakamura A; Taniguchi K; Tsurubuchi K; O'Hara K; Sawai T
Jpn J Antibiot; 1998 Jul; 51(7):494-500. PubMed ID: 9755433
[TBL] [Abstract][Full Text] [Related]
6. [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
Nakashio S; Iwasawa H; Iino S; Shimada J
Jpn J Antibiot; 1997 Oct; 50(10):844-53. PubMed ID: 9412874
[TBL] [Abstract][Full Text] [Related]
7. The incidence of inducible macrolide-lincosamide-streptogramin B resistance in methicillin-resistant staphylococci in clinical isolates from the Eastern Cape area of South Africa.
Gardee Y; Kirby R
Lett Appl Microbiol; 1993 Dec; 17(6):264-8. PubMed ID: 7764379
[TBL] [Abstract][Full Text] [Related]
8. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
Zarrouk V; Bozdogan B; Leclercq R; Garry L; Feger C; Carbon C; Fantin B
Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of macrolide, lincosamide, and streptogramin resistance among staphylococci in a tertiary care hospital in Athens, Greece.
Vallianou N; Evangelopoulos A; Hadjisoteriou M; Avlami A; Petrikkos G
J Chemother; 2015; 27(6):319-23. PubMed ID: 25112954
[TBL] [Abstract][Full Text] [Related]
10. RP 59500 postantibiotic effect defined by bacterial ultrastructure.
Lorian V; Amaral L; Fernandes F
Drugs Exp Clin Res; 1995; 21(3):125-8. PubMed ID: 7555615
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcus aureus with an erm-mediated constitutive macrolide-lincosamide-streptogramin B resistance phenotype has reduced susceptibility to the new ketolide, solithromycin.
Yao W; Xu G; Li D; Bai B; Wang H; Cheng H; Zheng J; Sun X; Lin Z; Deng Q; Yu Z
BMC Infect Dis; 2019 Feb; 19(1):175. PubMed ID: 30782125
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel insertion of the macrolides-lincosamides-streptogramin B resistance transposon Tn554 in methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Tillotson LE; Jenssen WD; Moon-McDermott L; Dubin DT
Antimicrob Agents Chemother; 1989 Apr; 33(4):541-50. PubMed ID: 2543284
[TBL] [Abstract][Full Text] [Related]
13. In-vitro activity of RP 59500, a new semisynthetic injectable pristinamycin against staphylococci.
von Eiff C; Peters G
Zentralbl Bakteriol; 1996 Apr; 283(4):497-501. PubMed ID: 8737948
[TBL] [Abstract][Full Text] [Related]
14. Studies of RP 59500 in vitro and in a rabbit model of aortic valve endocarditis caused by methicillin-resistant Staphylococcus aureus.
Chambers HF
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():117-22. PubMed ID: 1399943
[TBL] [Abstract][Full Text] [Related]
15. Methicillin-resistant, quinupristin-dalfopristin-resistant Staphylococcus aureus with reduced sensitivity to glycopeptides.
Werner G; Cuny C; Schmitz FJ; Witte W
J Clin Microbiol; 2001 Oct; 39(10):3586-90. PubMed ID: 11574577
[TBL] [Abstract][Full Text] [Related]
16. In-vitro and in-vivo synergic activity and fractional inhibitory concentration (FIC) of the components of a semisynthetic streptogramin, RP 59500.
Bouanchaud DH
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():95-9. PubMed ID: 1399956
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of macrolide, lincosamide and streptogramin B resistance in Staphylococcus aureus strains isolated from clinical samples by phenotypical and genotypical methods].
Aydeniz Ozansoy F; Cevahir N; Kaleli İ
Mikrobiyol Bul; 2015 Jan; 49(1):1-14. PubMed ID: 25706726
[TBL] [Abstract][Full Text] [Related]
18. A high frequency of macrolide-lincosamide-streptogramin resistance determinants in Staphylococcus aureus isolated in South Korea.
Kim HB; Lee B; Jang HC; Kim SH; Kang CI; Choi YJ; Park SW; Kim BS; Kim EC; Oh MD; Choe KW
Microb Drug Resist; 2004; 10(3):248-54. PubMed ID: 15383170
[TBL] [Abstract][Full Text] [Related]
19. Inducible clindamycin and methicillin resistant Staphylococcus aureus in a tertiary care hospital, Kathmandu, Nepal.
Adhikari RP; Shrestha S; Barakoti A; Amatya R
BMC Infect Dis; 2017 Jul; 17(1):483. PubMed ID: 28693489
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic interaction between RP 59500 and gram-positive bacteria infecting fibrin clots.
Turcotte A; Bergeron MG
Antimicrob Agents Chemother; 1992 Oct; 36(10):2211-5. PubMed ID: 1444302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
